Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Rigel updates R-788 program

April 13, 2007

Selective beta3-adrenoceptor agonists with reduced cardiac side effects reported by Lilly

April 13, 2007

Recent patents disclose novel antidiabetic agents

April 13, 2007

Follistim introduced in Japan for induction of ovulation in infertile women

April 12, 2007

Protemix raises funds to advance pipeline

April 12, 2007

Pilot bioavailability study for immediate release CDT-fenofibrate tablets

April 12, 2007

MediGene and JDRF collaborate on mTCR therapeutics for type 1 diabetes

April 12, 2007

Intrinsa launched in U.K.

April 11, 2007

FDA approves new coated Niaspan tablet

April 10, 2007

MB-07803 begins proof-of-concept study in type 2 diabetes

April 10, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...